Skip to content

Comparing exercise capacity, inflammation and endothelial function following cardioversion between asymptomatic and symptomatic patients with atrial fibrillation

Changes in exercise capacity, inflammation and endothelial function following cardioversion in asymptomatic versus symptomatic persistent atrial fibrillation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12614000857606
Enrollment
70
Registered
2014-08-08
Start date
2014-08-25
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, occurring in 1-2% of the population. Many patients remain asymptomatic, likely leading to an underestimation of the true prevalence of AF. Of particular importance is the similar risk of stroke and adverse health outcomes in the asymptomatic cohort. Catheter ablation has emerged as an effective treatment for symptomatic AF. However, the risk to benefit ratio of an ablation procedure in asymptomatic AF is less established. (i) Examine whether the restoration of sinus rhythm by cardioversion in asymptomatic patients improves exercise capacity to a similar degree as patients with symptomatic AF. (ii) Compare baseline and post-exercise parameters of the prothrombotic state between symptomatic and asymptomatic patients both before after cardioversion (1) We hypothesize that exercise capacity will be similarly impaired in symptomatic and asymptomatic patients and improve following restoration of sinus rhythm following cardioversion. (2) We further hypothesise that: a. acute exercise will elevate the prothrombotic state in both symptomatic and asymptomatic patients and; b. inflammation and endothelial dysfunction will be observed in both patient cohorts and similarly improved following the return of sinus rhythm.

Interventions

Direct electrical cardioversion. The cardioversion will be performed under sedation. Remote patches will be attached in Anterior-posterior or anterior-lateral position and 200 Joule synchronized shock will be delivered. A maximum of three shocks will be delivered to restore sinus rhythm. Cardioversion will be performed on a single occasion, lasting approximately 30 minutes.

Sponsors

Centre for Heart Rhythm Disorders
Lead SponsorUniversity

Study design

Allocation
Non-randomised trial
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

Persistent AF, defined as an episode of AF lasting longer than 7 days or lasts <7 days and requires direct cardioversion. Rate controlled during AF with resting ventricular rate less than 110bpm. Able and willing to provide written informed consent to participate.

Exclusion criteria

Patients contraindicated for exercise testing according to American Heart Association guidelines. Paroxysmal (AF duration <7 days) or Permanent AF (AF duration >1 year). Decompensated heart failure Unstable angina. Hemodynamic instability defined as systolic blood pressure less than 90mmHg. Previous AF ablation Pregnancy or suspected pregnancy

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026